Veracyte (VCYT) Hmangaihna Thlan
Veracyte
Thlanh chiah a ngai$45.45Updated 25 Sep 2026 19:59 UTC
Change-6.39%
AI forecast: VCYT
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Lai a ngaih a hnu a 6 thlang
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Ri hlaam thlan a nih hi
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumHmi hnuai thawn
Veracyte, Inc. develops molecular tests for cancer. The company offers molecular cytology and validates the accuracy of diagnostic results from cytological samples. Veracyte provides its products and services to healthcare and molecular diagnostics companies in the United States.
